- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 33 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.3: 10 residues within 4Å:- Chain A: G.16, S.17
- Chain B: E.57, N.58
- Chain G: R.104, P.105, W.106, N.107, I.108, L.112
2 PLIP interactions:2 interactions with chain G- Hydrogen bonds: G:N.107, G:N.107
NAG-NAG-BMA-MAN-MAN.10: 3 residues within 4Å:- Chain B: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.17: 5 residues within 4Å:- Chain B: V.104, N.106, N.118, Y.135, D.290
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.20: 10 residues within 4Å:- Chain C: G.16, S.17
- Chain D: E.57, N.58
- Chain I: R.104, P.105, W.106, N.107, I.108, L.112
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:N.107, I:N.107
NAG-NAG-BMA-MAN-MAN.27: 3 residues within 4Å:- Chain D: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.34: 5 residues within 4Å:- Chain D: V.104, N.106, N.118, Y.135, D.290
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.37: 10 residues within 4Å:- Chain E: G.16, S.17
- Chain F: E.57, N.58
- Chain K: R.104, P.105, W.106, N.107, I.108, L.112
2 PLIP interactions:2 interactions with chain K- Hydrogen bonds: K:N.107, K:N.107
NAG-NAG-BMA-MAN-MAN.44: 3 residues within 4Å:- Chain F: N.246, T.248, N.249
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.51: 5 residues within 4Å:- Chain F: V.104, N.106, N.118, Y.135, D.290
No protein-ligand interaction detected (PLIP)- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.5: 4 residues within 4Å:- Chain B: Q.100, S.120, F.121, N.122
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 3 residues within 4Å:- Chain B: S.357, N.361
- Ligands: NAG-NAG.14
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 4 residues within 4Å:- Chain D: Q.100, S.120, F.121, N.122
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.32: 3 residues within 4Å:- Chain D: S.357, N.361
- Ligands: NAG-NAG.31
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.39: 4 residues within 4Å:- Chain F: Q.100, S.120, F.121, N.122
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.49: 3 residues within 4Å:- Chain F: S.357, N.361
- Ligands: NAG-NAG.48
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.9: 10 residues within 4Å:- Chain B: K.35, E.181, V.224, L.231, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.16
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:G.348
NAG-NAG-BMA-MAN-MAN-MAN.26: 10 residues within 4Å:- Chain D: K.35, E.181, V.224, L.231, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.33
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:G.348
NAG-NAG-BMA-MAN-MAN-MAN.43: 10 residues within 4Å:- Chain F: K.35, E.181, V.224, L.231, N.232, N.346, G.348, V.414, S.415
- Ligands: NAG-NAG.50
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:G.348
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.52: 3 residues within 4Å:- Chain A: N.107, S.109, E.110
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.107, A:S.109, A:S.109
NAG.53: 1 residues within 4Å:- Chain B: N.107
No protein-ligand interaction detected (PLIP)NAG.54: 1 residues within 4Å:- Chain B: N.308
No protein-ligand interaction detected (PLIP)NAG.55: 7 residues within 4Å:- Chain B: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG.14, NAG-NAG.14
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.332, B:S.333, B:S.357
NAG.56: 3 residues within 4Å:- Chain C: N.107, S.109, E.110
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.107, C:S.109, C:S.109
NAG.57: 1 residues within 4Å:- Chain D: N.107
No protein-ligand interaction detected (PLIP)NAG.58: 1 residues within 4Å:- Chain D: N.308
No protein-ligand interaction detected (PLIP)NAG.59: 7 residues within 4Å:- Chain D: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG.31, NAG-NAG.31
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:N.332, D:S.333, D:S.357
NAG.60: 3 residues within 4Å:- Chain E: N.107, S.109, E.110
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:N.107, E:S.109, E:S.109
NAG.61: 1 residues within 4Å:- Chain F: N.107
No protein-ligand interaction detected (PLIP)NAG.62: 1 residues within 4Å:- Chain F: N.308
No protein-ligand interaction detected (PLIP)NAG.63: 7 residues within 4Å:- Chain F: N.332, S.333, T.341, N.355, S.357
- Ligands: NAG-NAG.48, NAG-NAG.48
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:N.332, F:S.333, F:S.357
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reveiz, M. et al., Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide. Front Immunol (2024)
- Release Date
- 2024-08-14
- Peptides
- Envelope glycoprotein gp41: ACE
Envelope glycoprotein gp120: BDF
antibody ACS202 Fab heavy chain: GIK
antibody ACS202 Fab light chain: HJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
AE
FB
GD
CF
IG
HI
DK
JH
LJ
EL
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 33 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 6 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reveiz, M. et al., Vaccine-elicited and naturally elicited antibodies differ in their recognition of the HIV-1 fusion peptide. Front Immunol (2024)
- Release Date
- 2024-08-14
- Peptides
- Envelope glycoprotein gp41: ACE
Envelope glycoprotein gp120: BDF
antibody ACS202 Fab heavy chain: GIK
antibody ACS202 Fab light chain: HJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
AE
FB
GD
CF
IG
HI
DK
JH
LJ
EL
K